EUCTR2005-001067-64-ES进行中（未招募）不适用
Multicentre study of optimization of therapy in mature B-cell acute lymphoblastic leukemia and Burkitt's lymphoma in adults (over 15 years) - BURKIMAB
PETHEMA Foundation0 个研究点目标入组 20 人开始时间: 2006年5月23日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.B mature cell Acute Lymphoblastic Leukemia (B-ALL, L3-ALL)
- •2.Burkitt´s and Burkitt´s-like Lymphoma
- •3.Age = 15 years
- •Written informed consent of the patient
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Serious uncontrolled medical conditions related to ALL3 or Burkitt´s Lymphoma or secondary diseases
- •Previous chemotherapy treatment
- •Pregnancy or breast feading
- •Psychiatric disorders
- •Current participation in another clinical trial interfering with the investigational treatment
研究者
相似试验
尚未招募
不适用
Multicenter clinical study on the optimal treatment protocol and outcome of cough variant asthma with Chinese and Western Medicinecough variant asthmaITMCTR2200005741The First Affiliated Hospital of Zhejiang Chinese Medical University
招募中
不适用
Multiple center study for establishing treatment of spinal scoliosisSpinal scoliosisJPRN-UMIN000002787Department of Orthopedic Surgery, Keio University School of Medicine1,000
招募中
不适用
Multicentre study about therapie management, nutrient supply and long-term outcome of patients with mild hyperphenylalaninemia and classical phenylketonuriaE70.0E70.1Classical phenylketonuriaOther hyperphenylalaninaemiasDRKS00004942niversität Leipzig50
已完成
不适用
Myogenous temporomandibular disorders (TMD), I. physiotherapy compared with occlusal splint therapy, and II. occlusal adjustment compared with occlusal splint therapy combined with occlusal adjustment, using therapy-and-patient-specific treatment durationsISRCTN17469828niversity Medical Centre Utrecht100
尚未招募
Unknown
Treatment of pediatric very high-risk acute lymphoblastic leukemia in KoreaNeoplasmsKCT0009352Seoul National University Hospital74